Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma

SIMPLE SUMMARY: Despite a negative SLN status, patients with Stage IIB/IIC melanoma demonstrate poor melanoma-specific survival when compared to Stage IIIA patients. In this study, we hypothesized that a molecular profile at the level of the SLN would provide potential insights into risk of disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Karapetyan, Lilit, Gooding, William, Li, Aofei, Yang, Xi, Knight, Andrew, Abushukair, Hassan M., Vargas De Stefano, Danielle, Sander, Cindy, Karunamurthy, Arivarasan, Panelli, Monica, Storkus, Walter J., Tarhini, Ahmad A., Kirkwood, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599365/
https://www.ncbi.nlm.nih.gov/pubmed/36291758
http://dx.doi.org/10.3390/cancers14204973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599365/
https://www.ncbi.nlm.nih.gov/pubmed/36291758
http://dx.doi.org/10.3390/cancers14204973

Ejemplares similares